Sunell Receives FDA Warning Letter

By Isabella Cheng, Published Mar 16, 2021, 11:06am EDT (Info+)

The US FDA has sent a warning letter to Sunell due to its sales of "adulterated and misbranded products", i.e. its widely relabelled Panda Cams.

In response, Sunell has taken down the problematic marketing and told IPVM "no more marketing multi-people scanning for fever cameras."

IPVM Image

** **** ******, **** ********:

  • *** *** ******* ******
  • ***** *** *** ***** ****** ********
  • ********* "** ** ** ******" ************ scanning ******
  • ****** *********** ******* ******** ****** ********
  • *** ****** ******* ***********
  • ****** ********

FDA ****** ******* ****** ** ****** *** "*********** *** ********** ********"

*** *** *** ****** ******** ******** ****** *** ******* ******* ******* marketing *** ******* ** **** ******** people **************.

IPVM Image

**** ******* ***** *** *** ****** similar ******* **** ***** ******* ******* ****** *********, ** **** ******** ******* **** month.

"Panda ***" ****** *****

******'* "***** ***" *** ****** **** OEMed ********** *** ******** *** *** easily ** ******** ********** *** ** its ****** ****** (*.*. ***** **** and ****).** ***** ** ************ *********** ** ** **** ***** relabeled *** ***** ***, *** **** widely ******** ** ***** ** **** security ****** ******** *****.

IPVM Image

2 ***** ****** ******* ****** ****** ********

******** ******'* ***** *** ** *** product **** ** **** ****** ***** and ************, *** ***'* ******* ****** also ******* ** ******'* "*********** ********* Thermographic ******* ****** ******" (**-***-*) *** "** ***** ********* ******* Camera **** ********** *********" (**-***-*-*). **** ** ***** ******* **** advertised ******** *********, ** ** ** targets *** *** ****** *** ** targets *** *** ******.

IPVM Image

***** *** ****** **** ******** ****** after *** ***** *** (** **** 2020 *** ***** ****), ***** ** likely *** **** **** *** **** as ************* **********.

Sunell ********* "******** *********" (** ** ** ******) ********* ******

** *** ****, ************* ***** *** *** ******* *** that ******'* ********* ** ******** ******** people (** **** ***** ** ** 45 ******) **** ************* ************** ******** ** ***** ******* *** conflicted **** *** *** *********** ***************.

****** *** ********** **** ********* ****** showing *** ****** ******** ** ** 45 ****** ** * ****.

IPVM Image

*** ***** ***'* ******* (************) *********** ****** ******** "** ** 45 *******."

IPVM Image

** *** **** *******, ****** ****** an ***** ** ****** ** ****** being ************** *******.

IPVM Image

********, ******'* ********* ********* ******** **** its *** *********** **********, ***** *** subjects ** ******** *** ****** ** a ****** **** ****, ******* ** walk **** *** *********, *** ****** straight ****** *** ******.

IPVM Image

*** *** *** *** ******** ******'* aggressive ********* ****** *** **** *** company * ******* ****** ***** ***** claims.

Not *** *** ********

*** ***, ***** *** ****, *** repeatedly *** ********** ****** ******* ******* systems ********** ******* *** ******** * ****. **** ** *** new ******** *** ****** *** **** thermal ******* ****** ********* ** ********.

Relabellers ********* ***** "********" *********

**** ********* ********* ******* "********" ****** screening ******* ** ******'* *********'* ********* materials. * *** ******** ** ********* faked ***/** ******* ********* ********* *** examined *****.

*****

***** *** **** ***** ********* ******** people ******** *** ****** ******** ******** screening *********** *** *******, **** ** **** ******* ***** (captured *****), **** **** ***** ** a ***** ** ***** ******** ****** are ******* ** ****:

IPVM Image

***** ******** * ***** ***** ******* * ********* ***** **** ****** 2020:

IPVM Image

******

******'********** ***************** ***** ** ********* ******** ***** of ******** ****** ***** *******. ******** people ** **** ***** **** **** on ** *****, ***** ***** ******** an ******** ****, ********** ***** *** Panda *** **** *** ******* ***** canthus ******** *** **** ******** ********. Further, *** ***** ***** ***** ** people **** ***** ***** ******* ****/****** away **** *** ******.

IPVM Image

*****, ****** ***** **** *** ****** can ****** ** ** ** *******.

IPVM Image

***********

************** **** ***** ******** ********* ** up ** ** ******, *** **** that **** *** ** ******. ***** on ****'* **** ***** ** ********* thermal ******** *******, ***** *** *********** challenges *** ********** ********* *** *********** of ****** ********, **** **** ** people *** ******.

IPVM Image

********

************ ****** ******** ****** ********* (**-** people ** ****). ** ****** *** Panda *** ** * "****** ******" ***** ****** *** ****** ** top ** * ******* ****. ***** DuThermX's ********* **** *** ****** ** "capable ** ******** **-** ******* **************," its ****** ****** ******* ***** **** people ****** ***** *** ******** **** either ** * ****** ** ****** lane *************. *****, **** "******** ****** detection" ***** ******* **** *********** **********.

IPVM ImageIPVM Image

FDA ********** ***** ***********, *** ****** ****** *****

*** *** *** ***** ******* ******* to *** **********, *** **** ** only ***** ** * ****** ********** that ***, ** ***, ******** * similar ******. ********, ***** **** ******** under ***** ********** *****, *** ********* ******* ********** *** *** *** *** **** reasons ****** ** ******. *****, ********'************* *********** ***** "******** ****** *********." Other ********* **** *** **** ***** blatantly ***** *********** (**** ** ***** specified ** **** ******) **** *** received ******* ********* ***** ***'* ******* ****** ********.

*** **** ** ******* ******* ****** to *********** ** * ***** ***** because *********** *** *********** *** **** of *** ****** ***** ** ***** cameras ** ***-*****. ** ******** ****** risk, *** *** **** *************** ****** the ********* ********* ** *** ****** relabellers *** *** ***********.

Sunell ********

**** ********* ***** *** *** ******* letter, ****** **** ****:

****** *** ********* ******** *** ******* letter *** **** **** ** ******** respond ** **** ** ********. ** the **** ****, *** **** *** already **** ********** ** ******* *** issues *** *** ******** ** **. We've ******* *** ************ ** *** FDA ******* *** ******* *** ******** descriptions *******. ***** **** ** ** more ********* *****-****** ******** *** ***** cameras.

******, ** ** ***** **, ****, the * ******** ****** ******' ****** webpages ** ****** ***** *****-****** *********.

** ***** **, ****** ****** **** IPVM *** ************* ******** *** ***, ********* ****** *** "removed *** ******* *** *********** ********* and ******* ***********" ****** * ***** of ********* *** ******* ******, ********* screenshots ** ******'* ******* ******* ***** the *******.

Comments (7)

Undisclosed Integrator #1

03/16/21 07:24pm

**** ****** ****** ***** ****. ** pun ******** 🤣😂

Agree
Disagree
Informative
Unhelpful
Funny

Undisclosed Manufacturer #2

03/16/21 09:20pm

**** *********. *************, *****'* *** ****** of **. ********* *********** ******** ** ad-dependent ** ****** *****-**** ** ******** makers *** *******. ** **** ******** it's ******** ***** *** *** ******, too- ****** *** ** ***** ****** it **** ******** ** ********.

Agree: 1
Disagree
Informative
Unhelpful
Funny
Avatar

Ryan Anderson

03/16/21 09:57pm

*** *** ***** ****** ***** ****** this *****?

Agree
Disagree
Informative
Unhelpful
Funny

John Honovich

IPVM | In reply to Ryan Anderson | 03/16/21 10:47pm

** *** **** ** *** ****, not **** ***** **** *** ********* greatly ******* ***** *** *****.

* ** ***** *** *********** ******* is ** *** ****** ***** ******* last **** ******** ** *****-****** ******** (which ** **** ***** *** ******* Sunell *********** **** ****), **** *** should **? *** *** ******** ** sue *** * ****** ** *** damages **** ***** * ******* **** violates *** ***********?

Agree
Disagree
Informative: 2
Unhelpful
Funny

Undisclosed Manufacturer #2

In reply to John Honovich | 03/17/21 12:15pm

*** *** ******** ** *** *** a ****** ** *** ******* **** using * ******* **** ******** *** regulations?

*'* **** *****'* * **** **** for ***** ** *** ****** ** go ******* *** ****, ******* *** expense ** ***** **. *** **'* dependent ** *** ****** ***** **** to ***** ********** ***** *** ********* they **** ***** *** ***** ** by *** ***** *****. **** ** facility ******** *** ****** ***** ******* might ** **** ******** ** ** that, ************ **** *** ******** ***** down *** *** **** *** **** solutions **********.

*'* **** **** ******* ******** *** now **** **** **** **** *** issue ***** **** (***** ** *** same **** ******* ** ***** ****** black ***** ** ******* *** ***** the ***** ** ****** *** **** them ** *** ********).

Agree: 1
Disagree
Informative
Unhelpful
Funny

John Honovich

IPVM | In reply to Undisclosed Manufacturer #2 | 03/17/21 12:18pm

*** **'* ********* ** *** ****** going **** ** ***** ********** ***** and ********* **** **** ***** *** taken ** ** *** ***** *****. Lots ** ******** ******** *** ****** board ******* ***** ** **** ******** to ** ****

* ***** ***** ****, **** *.*.,*** ********** **** **** ****** $***,*** of ********* *** ***** *******, ****'* ** ******* **** ** being ***** (*** ********* *** **********) but **** ***** **** **, ****** than ***** ***** *******.

Agree
Disagree
Informative: 1
Unhelpful
Funny

John Honovich

IPVM | 03/17/21 02:37pm

******: ***** *** ******* *** *******, removing ***** ****** *** ****** *** video ******* **** *** *** ********** *** ******* ** ******* *** individual ** * ****:

IPVM Image

**** ** **********. ***** ***** * year ****** ****** ** *** ***** products ***** ** *** '*******' ** screen ****** ** ****** ** **** and *** **** **** **** ***** money, **** ** *** *** '***, actually ** **** ********* ********* *** individual ** * ****.'

Agree: 1
Disagree
Informative
Unhelpful
Funny
Login to read this IPVM report.
Why do I need to log in?
IPVM conducts reporting, tutorials and software funded by subscriber's payments enabling us to offer the most independent, accurate and in-depth information.
Loading Related Reports